World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
10846
World Ranking
3729
National Ranking
140

J. Sjef Verbeek publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where J. Sjef Verbeek sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 133 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

J. Sjef Verbeek D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where J. Sjef Verbeek sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

J. Sjef Verbeek is affiliated with Leiden University Medical Center in the Netherlands and has contributed extensively to research in medicine, particularly focusing on immunology and oncology. Their work intersects multiple disciplines, including radiology, nuclear medicine, molecular biology, and genetics, with a strong emphasis on immunological mechanisms and cancer biology.

Their research mainly revolves around monoclonal and polyclonal antibodies, CAR-T cell therapy, and T-cell and B-cell immunology. Additional areas of focus include glycosylation and glycoproteins, chronic lymphocytic leukemia, immune cell function and interaction, and the role of galectins in cancer biology.

Frequent co-authors collaborating with Verbeek include:

  • Mark S. Cragg
  • Shozo Izui
  • Hreinn Benonisson
  • Conny Brouwers
  • Margot M. Linssen

Their publications appear in various scientific outlets, highlighting contributions to multiple high-impact journals. The frequent venues of publication are:

  • Cancer Cell
  • Clinical & Experimental Immunology
  • Cell Reports
  • Cancers
  • Scientific Reports

Notable recent papers authored or co-authored by Verbeek include:

  • "Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity," 2020, Cancer Cell
  • "Isotype selection for antibody-based cancer therapy," 2020, Clinical & Experimental Immunology
  • "Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice," 2021, Cancers
  • "Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors," 2022, Cell Reports
  • "Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment," 2020, Scientific Reports

Best Publications

  • Arthritis Critically Dependent on Innate Immune System Players

    Hong Ji;Koichiro Ohmura;Koichiro Ohmura;Umar Mahmood;David M Lee

  • Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection

    Matthew J. Robinson;Fabiola Osorio;Marcela Rosas;Rui P. Freitas

  • Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice

    Wouter L.W Hazenbos;J.Engelbert Gessner;Frans M.A Hofhuis;Henri Kuipers

  • Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

    Stephen A. Beers;Ruth R. French;H. T. Claude Chan;Sean H. Lim

  • FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

    A Ioan-Facsinay;S.J de Kimpe;S.M.M Hellwig;P.L van Lent

  • Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo

    Danita H. Schuurhuis;Andreea Ioan-Facsinay;Bas Nagelkerken;Jolien J. van Schip

  • Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes

    Leendert A. Trouw;Tom W.L. Groeneveld;Marc A. Seelen;Jacques M.G.J. Duijs

  • Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody

    Ann L. White;H. T. Claude Chan;Ali Roghanian;Ruth R. French

  • Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.

    Liliane Fossati-Jimack;A. Ioan-Facsinay;Luc Reininger;Yves Chicheportiche

  • Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses.

    Frank A Redegeld;Maurice W van der Heijden;Mirjam Kool;Bianca M Heijdra

  • Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody

    Samareh Azeredo da Silveira;Shuichi Kikuchi;Liliane Fossati-Jimack;Thomas Moll

  • Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

    Pim J Koelink;Felicia M Bloemendaal;Bofeng Li;Liset Westera

  • Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

    Ann L. White;H.T. Claude Chan;Ruth R. French;Jane E. Willoughby

  • Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18).

    Marjolein van Egmond;A.J. Hanneke van Vuuren;H. Craig Morton;Annemiek B. van Spriel

  • A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction

    Ulrich Baumann;Jörg Köhl;Thomas Tschernig;Kirsten Schwerter-Strumpf

  • Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity

    Nadine van Montfoort;Marcel G. Camps;Selina Khan;Dmitri V. Filippov

  • CD16 promotes Escherichia coli sepsis through an FcR$\gamma$ inhibitory pathway that prevents phagocytosis and facilitates inflammation

    Fabiano Pinheiro da Silva;Fabiano Pinheiro da Silva;Fabiano Pinheiro da Silva;Meryem Aloulou;Meryem Aloulou;David Skurnik;Marc Benhamou;Marc Benhamou

  • C5a Initiates the Inflammatory Cascade in Immune Complex Peritonitis

    Jeanne Godau;Tanja Heller;Heiko Hawlisch;Matthew Trappe

  • Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.

    Sarah L. Buchan;Lang Dou;Marcus Remer;Steven G. Booth

  • Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine

    Danita H. Schuurhuis;Nadine van Montfoort;Andreea Ioan-Facsinay;Reshma Jiawan

  • Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.

    Julia Skokowa;Syed R. Ali;Olga Felda;Varsha Kumar

Frequent Co-Authors

Ferry Ossendorp
Ferry Ossendorp Leiden University Medical Center
Shozo Izui
Shozo Izui University of Geneva
Martin J. Glennie
Martin J. Glennie University of Southampton
Mark S. Cragg
Mark S. Cragg University of Southampton
Cornelis J. M. Melief
Cornelis J. M. Melief ISA Pharmaceuticals (Netherlands)
Thorbald van Hall
Thorbald van Hall Leiden University Medical Center
Jeanette H. W. Leusen
Jeanette H. W. Leusen Utrecht University
Falk Nimmerjahn
Falk Nimmerjahn University of Erlangen-Nuremberg
Takashi Saito
Takashi Saito Nagoya City University
Jan G. J. van de Winkel
Jan G. J. van de Winkel Genmab (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can enhance career prospects. Nursing offers a strong foundation in patient care and biological sciences, often intersecting with immunological principles. Many non-nurses looking to enter nursing can benefit from accelerated programs, such as the 12-month accelerated nursing programs online for non nurses. These programs provide a fast track into nursing with flexible online options.

Finding the right Bachelor of Science in Nursing (BSN) program can be crucial. Prospective students may want to consider the easiest ABSN program to get into for a smoother admission experience without compromising quality education.

Licensed Practical Nurse (LPN) programs can also be an accessible entry point into nursing careers. The best easiest LPN programs to get into help streamline admission, allowing students to quickly join the healthcare workforce and gain practical experience.

Advanced practice nurses looking to specialize might explore the easiest nurse practitioner program options, which offer accelerated pathways and flexible formats. These programs enable nurses to expand their scope of practice, often including immunology-related specialties.

Best Scientists Citing J. Sjef Verbeek

Trending Scientists

Recently Published Articles